Metraipolis › archive › dc_d8aab5460123
Sex-Specific Real-Life Profiling in Vedolizumab, Ustekinumab, and Tofacitinib Effectiveness in Ulcerative Colitis — Europe PMC PMID:41226873
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41226873
- DOI
- 10.3390/jcm14217476
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T03:30:14.719Z
- SHA-256 of the archived text
a3ee9e9566240f12f2d9722cd8b0e9ff12bf334c088fea853d91ce851f43961c- Stable URL of this page
https://metraipolis.com/documento/dc_d8aab5460123
How to cite
Sex-Specific Real-Life Profiling in Vedolizumab, Ustekinumab, and Tofacitinib Effectiveness in Ulcerative Colitis — Europe PMC PMID:41226873 — Europe PMC (en), https://europepmc.org/article/MED/41226873 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d8aab5460123 (Metraipolis archive dc_d8aab5460123, sha256 a3ee9e9566240f12f2d9722cd8b0e9ff12bf334c088fea853d91ce851f43961c)
BibTeX
@misc{dcd8aab5460123,
title = {Sex-Specific Real-Life Profiling in Vedolizumab, Ustekinumab, and Tofacitinib Effectiveness in Ulcerative Colitis — Europe PMC PMID:41226873},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41226873},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d8aab5460123; sha256 a3ee9e9566240f12f2d9722cd8b0e9ff12bf334c088fea853d91ce851f43961c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41226873. Agents can read the archived copy with the MCP tool read_document.